Literature DB >> 2989614

Comparison of serum angiotensin-converting enzyme in Graves' disease, toxic nodular goiter, and other thyroid conditions.

H Czernobilsky, W Fiehn, R Ziegler.   

Abstract

Angiotensin-converting enzyme (ACE) was measured in plasma of patients with Graves' disease and with toxic nodular goiter, as well as in their treated counterparts and in normal controls. A significant elevation of ACE levels and a positive correlation between ACE, thyroxine, and triiodothyronine levels was found in both groups of thyrotoxicosis. Parallel fluctuations of triiodothyronine and ACE levels, albeit with a certain lag of the latter, was observed in patients in whom multiple measurements were taken. ACE levels, which were also determined in hypothyroid patients and in patients with euthyroid goiter on suppression therapy, were in the same range as normal controls and as in treated thyrotoxic patients. We conclude that the pathogenesis of thyrotoxicosis does not play a role in ACE elevation but that increased thyroid hormone seems to induce elevation of ACE. ACE elevation in thyrotoxicosis may constitute an integral part of the renin-angiotensin axis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989614     DOI: 10.1007/bf01747982

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

1.  Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.

Authors:  J Lieberman
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

2.  Plasma renin activity in hyper- and hypothyroidism: effect of adrenergic blocking agents.

Authors:  J H Hauger-Klevene; H Brown; J Zavaleta
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

3.  The prevalence of thyroid-stimulating antibodies in goitrous disease assessed by cytochemical section bioassay.

Authors:  P P Smyth; D Neylan; D K O'Donovan
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

4.  Increased levels of serum angiotensin-converting enzyme activity in hyperthyroidism.

Authors:  H Yotsumoto; Y Imai; N Kuzuya; H Uchimura; F Matsuzaki
Journal:  Ann Intern Med       Date:  1982-03       Impact factor: 25.391

5.  Plasma inactive renin in patients with hyperthyroidism.

Authors:  M Nakamaru; T Ogihara; J Higaki; Y Kumahara; K Murakami; K Kuma
Journal:  J Clin Endocrinol Metab       Date:  1983-01       Impact factor: 5.958

6.  Elevation of serum angiotensin-converting enzyme activity in patients with hyperthyroidism.

Authors:  Y Nakamura; T Takeda; M Ishii; K Nishiyama; M Yamakada; Y Hirata; K Kimura; S Murao
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

7.  The renin-angiotensin system in panhypopituitarism: dynamic studies and therapeutic effects in Sheehan's syndrome.

Authors:  F Bakiri; M Benmiloud; M B Vallotton
Journal:  J Clin Endocrinol Metab       Date:  1983-05       Impact factor: 5.958

8.  Serum angiotensin-converting enzyme. Alterations in hyperthyroidism, hypothyroidism, and subacute thyroiditis.

Authors:  R C Smallridge; J Rogers; P S Verma
Journal:  JAMA       Date:  1983-11-11       Impact factor: 56.272

9.  Effects of hyper- and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin-angiotensin system in male rats.

Authors:  E Jiménez; M Montiel; J A Narváez; M Morell
Journal:  Rev Esp Fisiol       Date:  1982-06

10.  Elevated serum angiotensin-converting enzyme in hyperthyroidism.

Authors:  E Silverstein; G C Schussler; J Friedland
Journal:  Am J Med       Date:  1983-08       Impact factor: 4.965

View more
  3 in total

1.  Why is plasma angiotensin-converting enzyme activity elevated in hyperthyroidism?

Authors:  J E Roulston; A Gold; M Wright; S W Walker
Journal:  J R Soc Med       Date:  1987-08       Impact factor: 5.344

2.  Association of Angiotensin-Converting Enzyme (ACE) Gene Polymorphism with Inflammation and Cellular Cytotoxicity in Vitiligo Patients.

Authors:  Laila Rashed; Rania Abdel Hay; Rania Mahmoud; Nermeen Hasan; Amr Zahra; Salwa Fayez
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

3.  Biomarkers and Gene Polymorphisms in Members of Long- and Short-lived Families: A Longevity Study.

Authors:  Vana Kolovou; Olga Diakoumakou; Athanasia K Papazafiropoulou; Niki Katsiki; Elisabeth Fragopoulou; Ioannis Vasiliadis; Dimitris Degiannis; Leonidas Duntas; Smaragdi Antonopoulou; Genovefa Kolovou
Journal:  Open Cardiovasc Med J       Date:  2018-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.